Literature DB >> 20593634

Association of antimicrobial and clinical efficacy: periodontitis therapy with minocycline microspheres.

Paul S Bland1, J Max Goodson, John C Gunsolley, Sara G Grossi, Joan Otomo-Corgel, Frances Doherty, Judith L Comiskey.   

Abstract

OBJECTIVE: The objective of this study was to investigate the association between the antimicrobial and clinical efficacy of minocycline hydrochloride microspheres when used adjunctively with scaling and root planing.
METHODS: 127 subjects with moderate-to-advanced chronic periodontitis were randomly assigned to receive either minocycline microspheres plus scaling and root planing (n = 62) or scaling and root planing alone (n = 65). Deoxyribose nucleic acid analysis and clinical data were obtained at baseline and 30 days after treatment. End points included changes in the mean sum of red complex bacteria, pocket depth, number of deep pockets, bleeding on probing, and clinical attachment level from baseline to day 30. Regression analysis determined the association between microbiological and clinical efficacy.
RESULTS: Minocycline microspheres plus scaling and root planing reduced pocket depth, the number of deep pockets and bleeding on probing, and increased clinical attachment level significantly more than scaling and root planing alone (p < 0.05). Comparing minocycline microspheres plus scaling and root planing with scaling and root planing alone, the number needed to treat for a 2 mm pocket depth reduction difference was 6.5. Pocket depth reduction correlated significantly with a decrease in the numbers and proportions of red complex bacteria. Minocycline microspheres significantly improved all clinical parameters compared to scaling and root planing alone.
CONCLUSIONS: The addition of minocycline microspheres to scaling and root planing led to a greater reduction in the proportions and numbers of red complex bacteria. The reduction in pocket depth was significantly correlated with the reduction of the proportions and numbers of red complex bacteria. Additionally, there were statistically greater improvements in all clinical parameters examined.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20593634

Source DB:  PubMed          Journal:  J Int Acad Periodontol        ISSN: 1466-2094


  7 in total

1.  A mini-review on novel intraperiodontal pocket drug delivery materials for the treatment of periodontal diseases.

Authors:  H Hau; R Rohanizadeh; M Ghadiri; W Chrzanowski
Journal:  Drug Deliv Transl Res       Date:  2014-06       Impact factor: 4.617

2.  Practice based research networks impacting periodontal care: PEARL Initiative.

Authors:  Frederick A Curro; Van P Thompson; Ashley Grill; Don Vena; Louis Terracio; Frederick Naftolin
Journal:  J Periodontol       Date:  2012-06-15       Impact factor: 6.993

3.  Clinical and microbiological results following nonsurgical periodontal therapy with or without local administration of piperacillin/tazobactam.

Authors:  Marc Lauenstein; Marion Kaufmann; G Rutger Persson
Journal:  Clin Oral Investig       Date:  2013-01-20       Impact factor: 3.573

Review 4.  Current Concepts in the Management of Periodontitis.

Authors:  TaeHyun Kwon; Ira B Lamster; Liran Levin
Journal:  Int Dent J       Date:  2021-02-19       Impact factor: 2.607

Review 5.  Professionally Delivered Local Antimicrobials in the Treatment of Patients with Periodontitis-A Narrative Review.

Authors:  Amar Sholapurkar; Dileep Sharma; Beverley Glass; Catherine Miller; Alan Nimmo; Ernest Jennings
Journal:  Dent J (Basel)       Date:  2020-12-22

6.  Treatment modalities and evaluation models for periodontitis.

Authors:  Mohammad Tariq; Zeenat Iqbal; Javed Ali; Sanjula Baboota; Sushama Talegaonkar; Zulfiqar Ahmad; Jasjeet K Sahni
Journal:  Int J Pharm Investig       Date:  2012-07

7.  Antiseptics as adjuncts to scaling and root planing in the treatment of periodontitis: a systematic literature review.

Authors:  Egle Ramanauskaite; Vita Machiulskiene
Journal:  BMC Oral Health       Date:  2020-05-18       Impact factor: 2.757

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.